Delivery Order SPE2DR25D2009-SPE2DR26FJ3D1
Award Date 11/13/25
Potential Completion Date 11/14/25
Potential Value $204K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $140,147 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The order will be fulfilled at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This is a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal vaccine...
- The Defense Logistics Agency awarded a delivery order valued at $1,060.99 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price contract was issued on November 5, 2025, with an ultimate completion date of November 6, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major hub for pharmaceutical distribution operations. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,435.48 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe format (0.5mL). This non-set-aside contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a firm fixed-price delivery order. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a key distribution hub for the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $71,577.02 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,977.18 for Boostrix TDAP vaccine in 0.5mL syringes on November 12, 2025, with completion expected by November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, valued at $5,119.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by November 10, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at approximately $31K to AmerisourceBergen Drug Corp for supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 13, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was awarded on August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,828.91 for Boostrix TDAP vaccine in 0.5mL syringes on November 12, 2025, with completion scheduled for November 13, 2025. This non-set-aside, firm fixed-price contract represents a straightforward pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,377.20 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5ML syringes. This firm fixed price, competitively awarded contract has an ultimate completion date of November 3, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in open...